实体瘤与血液系统恶性肿瘤中的肿瘤免疫治疗：进展、挑战与实践框架

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

整合素 β6 靶向 CAR-T 细胞在 β6 阳性胰腺导管腺癌和肺腺癌中表现出强效抗肿瘤活性

Integrin β6-Targeted CAR-T Cells exhibit potent antitumor activity in β6-Positive pancreatic ductal adenocarcinoma and lung adenocarcinoma.

CAR-T 疗法在实体瘤中的应用：当前机遇与挑战

Application of CAR-T therapy in solid tumors: current opportunities and challenges.

整合转录组学与蛋白质组学验证确定 SLC35D3 为结直肠癌与神经内分泌癌的肿瘤选择性表面抗原

Integrated transcriptomic and proteomic validation identifies SLC35D3 as a tumor-selective surface antigen for colorectal and neuroendocrine carcinoma

靶向 γ-分泌酶复合物调控高侵袭性恶性肿瘤中的致癌 NOTCH 信号：一项系统综述

Modulation of Oncogenic NOTCH Signaling in Highly Aggressive Malignancies by Targeting the γ-Secretase Complex: A Systematic Review.

共同 γ 链细胞因子驱动的 CAR-T 细胞优化：机制见解与未来方向

Common gamma chain cytokines-driven optimization of chimeric antigen receptor T cells: Mechanistic insights and future directions.

通过 IL-7、IL-15 和 CCL19 共存效应增强 B7-H3 CAR-T 细胞对胰腺和肺异种移植瘤的疗效

Enhancement of B7-H3 chimeric antigen receptor-T cell efficacy via the coexistence effect of IL-7, IL-15 and CCL19 for pancreatic and lung xenograft t

靶向 CD155 的 CAR-T 细胞降低白血病和实体瘤临床前模型中的肿瘤负荷

CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors.

靶向 Eva1（MPZL2）的 CAR-T 细胞的开发与优化

Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.

这些数据表明，人源化 Eva1CAR-T 在治疗多种 Eva1 阳性实体瘤方面具有有前景的治疗潜力。

实体瘤中靶向 AXL 的新型 mRNA 工程化全人源 CAR-T 细胞

Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors.